| Kimberly O Drakes, LNM | |
|
1131 West St, Bldg 2, Southington, CT 06489-6006 | |
| (860) 276-6800 | |
| Not Available |
| Full Name | Kimberly O Drakes |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 18 Years |
| Location | 1131 West St, Southington, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316373665 | NPI | - | NPPES |
| 000285 | Other | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 000285 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians For Women's Health, Llc | 3274430665 | 278 |
| Planned Parenthood Of Southern New England Inc | 3173436730 | 26 |
| Trinity Health Of New England Provider Network Organization Inc | 0941113567 | 621 |
News Archive
In this Washington Post opinion piece, columnist Michael Gerson examines anti-malaria efforts in Zambia, writing, "Zambia has been the main test case for anti-malaria efforts during the last several years - a focus of funding by the U.S. government, the [Bill & Melinda Gates Foundation] and the Global Fund to Fight AIDS, Tuberculosis and Malaria."
The Diabetes Resource Center at Sinai Hospital of Baltimore has been awarded recertification by the American Diabetes Association Education Recognition program.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
Men and women react differently to compounds associated with immune system response to bipolar disorder, according to Penn State College of Medicine researchers.
› Verified 3 days ago
| Entity Name | Planned Parenthood Of Southern New England Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174633143 PECOS PAC ID: 3173436730 Enrollment ID: O20031110000416 |
News Archive
In this Washington Post opinion piece, columnist Michael Gerson examines anti-malaria efforts in Zambia, writing, "Zambia has been the main test case for anti-malaria efforts during the last several years - a focus of funding by the U.S. government, the [Bill & Melinda Gates Foundation] and the Global Fund to Fight AIDS, Tuberculosis and Malaria."
The Diabetes Resource Center at Sinai Hospital of Baltimore has been awarded recertification by the American Diabetes Association Education Recognition program.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
Men and women react differently to compounds associated with immune system response to bipolar disorder, according to Penn State College of Medicine researchers.
› Verified 3 days ago
| Entity Name | Trinity Health Of New England Provider Network Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003882812 PECOS PAC ID: 0941113567 Enrollment ID: O20031110000651 |
News Archive
In this Washington Post opinion piece, columnist Michael Gerson examines anti-malaria efforts in Zambia, writing, "Zambia has been the main test case for anti-malaria efforts during the last several years - a focus of funding by the U.S. government, the [Bill & Melinda Gates Foundation] and the Global Fund to Fight AIDS, Tuberculosis and Malaria."
The Diabetes Resource Center at Sinai Hospital of Baltimore has been awarded recertification by the American Diabetes Association Education Recognition program.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
Men and women react differently to compounds associated with immune system response to bipolar disorder, according to Penn State College of Medicine researchers.
› Verified 3 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
In this Washington Post opinion piece, columnist Michael Gerson examines anti-malaria efforts in Zambia, writing, "Zambia has been the main test case for anti-malaria efforts during the last several years - a focus of funding by the U.S. government, the [Bill & Melinda Gates Foundation] and the Global Fund to Fight AIDS, Tuberculosis and Malaria."
The Diabetes Resource Center at Sinai Hospital of Baltimore has been awarded recertification by the American Diabetes Association Education Recognition program.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
Men and women react differently to compounds associated with immune system response to bipolar disorder, according to Penn State College of Medicine researchers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly O Drakes, LNM 1131 West St, Bldg 2, Southington, CT 06489-6006 Ph: (860) 276-6800 | Kimberly O Drakes, LNM 1131 West St, Bldg 2, Southington, CT 06489-6006 Ph: (860) 276-6800 |
News Archive
In this Washington Post opinion piece, columnist Michael Gerson examines anti-malaria efforts in Zambia, writing, "Zambia has been the main test case for anti-malaria efforts during the last several years - a focus of funding by the U.S. government, the [Bill & Melinda Gates Foundation] and the Global Fund to Fight AIDS, Tuberculosis and Malaria."
The Diabetes Resource Center at Sinai Hospital of Baltimore has been awarded recertification by the American Diabetes Association Education Recognition program.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
Men and women react differently to compounds associated with immune system response to bipolar disorder, according to Penn State College of Medicine researchers.
› Verified 3 days ago
Michelle Plyler, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1131 West St, Bldg 2, Southington, CT 06489 Phone: 860-276-6800 Fax: 860-276-6801 |